SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is currently trending as investors debate the impact of a reported delay in its "Avocado" AI model, with community sentiment split between concerns over the massive capital expenditures versus bullish confidence in the company's long-term dominance in AI monetization. Traders are actively monitoring technical support levels around the $600-$620 range and closely tracking Meta's aggressive strategy to develop in-house AI chips to reduce reliance on third-party suppliers.

Trump For President

$TRUMP is experiencing heightened volatility and community debate following a 50% price spike sparked by rumors of a gala invite for top holders. The conversation remains deeply polarized, with critics labeling it a speculative scam and political grift, while proponents view the price action as a signal of continued speculative interest.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is facing significant volatility ahead of its upcoming earnings report, with sentiment currently polarized between investors betting on a potential acquisition and those concerned about the company's competitive position and leadership transition. The community remains highly focused on the firm's AI-driven growth trajectory versus broader macroeconomic pressures, with many traders closely monitoring for a technical breakout or potential buyout catalyst.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the online community fiercely debate the financial implications of the ongoing conflict in Iran, with many scrutinizing the administration's policy decisions and their direct impact on oil prices and market stability. The discourse is highly polarized, featuring intense arguments over the company's valuation, geopolitical risks, and the stock's role as a barometer for the broader MAGA political movement.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is currently seeing heightened community activity and speculation as investors debate its potential for a rebound amidst broader meme coin market volatility. Discussions are heavily focused on varying perspectives regarding the token's long-term utility versus its speculative nature, with many users actively coordinating to push for price movements while others express skepticism about its past performance.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending as investors gear up for the upcoming annual earnings report, with widespread anticipation of a significant new share buyback program and strong profit guidance. The community remains overwhelmingly bullish, highlighting the company's robust position in the defense and aerospace sectors and its ongoing turnaround success.

Silvaco Group, Inc. provides technology computer aided design software, electronic data automation software and semiconductor intellectual property. The TCAD, EDA and SIP solutions enable semiconductor and photonics companies to increase productivity, accelerate their product's time to market and reduce their development and manufacturing costs. Its services include SPICE Modeling Services, TCAD Modeling Services, Library Design Services and Library Characterization Services. The company was founded on November 18, 2009 and is headquartered in Santa Clara, CA.

Silvaco Group Inc.

Silvaco Group is seeing increased attention as traders track its momentum following a series of recent insider purchases and positive analyst coverage. The community is actively discussing the stock's potential for growth in the semiconductor software space, with many monitoring for volume triggers that could drive further price action.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is trending as investors weigh the significant supply chain risks and potential for sustained crude price surges following escalating Middle East conflict and the closure of the Strait of Hormuz. While some traders view the sector as a long-term hedge and potential beneficiary of geopolitical instability, others are debating whether the recent price appreciation is already exhausted or if a broader shift toward energy security will drive further gains.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is attracting intense investor attention following positive early prescription data and key medical necessity inclusions from major insurance providers for its flagship fibromyalgia treatment, TONMYA. While the community is sharply divided between optimistic bulls betting on a potential short squeeze and long-term pipeline value and skeptical bears highlighting concerns over past share dilution and ongoing cash burn, the stock remains a high-volatility focal point for traders.

Goodyear Tire & Rubber Co. engages in the development, manufacture, distribution, and sale of tires. It operates through the following geographical segments: Americas, Europe, Middle East, and Africa, and Asia Pacific. The Americas segment is involved in the development, manufacture, distribution, and sale of tires and related products and services in North, Central, and South America. The Europe, Middle East, and Africa segment focuses on the development, manufacture, distribution, and sale of tires for automobiles, trucks, buses, aircraft, motorcycles, earthmoving, mining, and industrial equipment throughout Europe, the Middle East, and Africa. The Asia Pacific segment refers to the development, manufacture, distribution, and sales of tires for automobiles, trucks, buses, aircraft, farm, earthmoving, mining, and industrial equipment throughout the Asia Pacific region. The company was founded by Frank A. Seiberling on August 29, 1898 and is headquartered in Akron, OH.

Goodyear Tire & Rubber Co.

Goodyear Tire & Rubber Co. is facing intense downward pressure driven by earnings disappointments, high debt concerns, and broader market skepticism regarding its turnaround plan. Despite community debate over its depressed valuation and potential for long-term recovery through automotive demand, traders are currently fixated on significant volatility and aggressive shorting activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$KAPA I noted three things in particular from the 12/10/25 podcast interview of Doctor Bhowmick.  (1) at 14:00 time stamp, NIH provided funding to the company of $3.2 million for companion biomarker study of prostate cancer, DoD provided $1.2 million to the company for companion biomarker study of lung cancer;  (2) at 23:20, Kairos is speaking to big pharma about their various trial work;  (3) at 24:20, prostate cancer phase 2 study completion in about 12 months from time of interview (1/2027 is the estimated primary completion date, and also the study completion date, shown on the trial plan - see clinicaltrials.gov), lung cancer phase 1 study completion in about 18 months from time of interview (1/2027 is the primary completion date shown on the trial plan, 1/2028 is the study completion date shown on the trial plan - see clinicaltrials.gov).  That was my takeaway from the interview, you may hear it differently.

C Gantz

Philip Cornman

Buck

Clinicaltrials

ClinicalTrials.gov

StockTwits For Android 

Kairos Pharma Ltd.

 I noted three things in particular from the 12/10/25 podcast interview of Doctor Bhowmick.  (1) at 14:00 time stamp, NIH provided funding to the company of $3.2 million for companion biomarker study of prostate cancer, DoD provided $1.2 million to the company for companion biomarker study of lung cancer;  (2) at 23:20, Kairos is speaking to big pharma about their various trial work;  (3) at 24:20, prostate cancer phase 2 study completion in about 12 months from time of interview (1/2027 is the estimated primary completion date, and also the study completion date, shown on the trial plan - see 

), lung cancer phase 1 study completion in about 18 months from time of interview (1/2027 is the primary completion date shown on the trial plan, 1/2028 is the study completion date shown on the trial plan - see 

).  That was my takeaway from the interview, you may hear it differently.